The biological effects of three probiotic strains Lactobacillus rhamnosus K32, Bifidobacterium longum GT15, Enterococcus faecium L3 and their mixture were studied using a model of dysbiosis induced in rats by antibiotics. It was found that after taking different probiotics intestinal microbiota changed in a strain-specific manner. The maximal activity against pathogens was revealed after the administration of a mixture of bacterial strains under study or a single strain of enterococci. The strain E. faecium L3 showed the most activity against both Klebsiella spp. and Bacteroides fragilis. It helped to restore the original content of Faecalibacterium prausnitzii. The number of Klebsiella spp. was the same in the group receiving L. rhamnosus K32 and the group of animals, which was not consuming probiotics. Different probiotic strains included in the composition had various immunological effects. Probiotic bifidobacteria, enterococci and the mixture of three probiotics stimulated of mRNA expression of interleukin (IL)-10 in mesenteric lymph nodes. The changes in microbiota after consuming an enterococcal probiotic correlated with an increase in transforming growth factor (TGF)-β and IL-10 content in blood serum and an increase of the intestinal mucus layer. Consumption of L. rhamnosus K32 led to the stimulation of IL-8 expression in mesenteric lymph nodes. Control group not receiving probiotics was characterised by expression of pro-inflammatory cytokines, damage of epithelial cells and the destruction of their tight junctions. The damage to the ultrastructure of the mucosa was prevented in all the groups taking probiotics.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Abdurasulova, I.N., Matsulevich, A.V., Tarasova, E.A., Kudryavtsev, I.V., Serebrjakova, M.K., Ermolenko, E.I., Bisaga, G.N., Klimenko, V.M. and Suvorov, A.N., 2016. Enterococcus faecium strain L-3 and glatiramer acetate ameliorate experimental allergic encephalomyelitis in rats by affecting different populations of immune cells. Beneficial Microbes 7: 719-729.
'Enterococcus faecium strain L-3 and glatiramer acetate ameliorate experimental allergic encephalomyelitis in rats by affecting different populations of immune cells ' () 7 Beneficial Microbes : 719 -729.
Ahrne, S. and Hagslatt, M.-L.J., 2011. Effect of Lactobacilli on paracellular permeability in the gut. Nutrients 3: 104-117.
'Effect of Lactobacilli on paracellular permeability in the gut ' () 3 Nutrients : 104 -117.
Averina, O.V., Ermolenko, E.I., Borschev, Y., Yu Leontieva, G.F., Kramskaya, T.A., Kotyleva, M.P., Danilenko, V.N. and Suvorov, A.N., 2015. Influence of probiotics on cytokine production in the in vitro and in vivo systems. Meditsinskaya Immunologiya 17: 443-454.
'Influence of probiotics on cytokine production in the in vitro and in vivo systems ' () 17 Meditsinskaya Immunologiya : 443 -454.
Blum, S. and Schiffrin, E.J., 2003. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria? Current Issues in Molecular Biology 4: 53-60.
'Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria? ' () 4 Current Issues in Molecular Biology : 53 -60.
Burger-Van Paassen, N., Vincent, A., Puiman, P.J., Van der Sluis, M., Bouma, J., Boehm, G., Van Goudoever, J.B., Van Seuningen, I. and Renes, I.B., 2009. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochemical Journal 420: 211-219.
'The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection ' () 420 Biochemical Journal : 211 -219.
Chapman, C.M.C., Gibson, G.R. and Rowland, I., 2011. Health benefits of probiotics: are mixtures more effective than single strains? European Journal of Nutrition 50: 1-17.
'Health benefits of probiotics: are mixtures more effective than single strains? ' () 50 European Journal of Nutrition : 1 -17.
Distrutti, E., Monaldi, L., Ricci, P. and Fiorucci, S., 2016. Gut microbiota role in irritable bowel syndrome: new therapeutic strategies. World Journal of Gastroenterology 22: 2219-2241.
'Gut microbiota role in irritable bowel syndrome: new therapeutic strategies ' () 22 World Journal of Gastroenterology : 2219 -2241.
Eeckhaut, V., Machiels, K., Perrier, C., Romero, C., Maes, S., Flahou, B., Steppe, M., Haesebrouck, F., Sas, B., Ducatelle, R., Vermeire, S. and Van Immerseel, F., 2013. Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62: 1745-1752.
'Butyricicoccus pullicaecorum in inflammatory bowel disease ' () 62 Gut : 1745 -1752.
Ermolenko, E.I., 2014. Immunomodulatory effect of probiotic bacteria in case of the diseases of gastrointestinal tract. Bulletin of St. Petersburg State University 4: 5-18.
'Immunomodulatory effect of probiotic bacteria in case of the diseases of gastrointestinal tract ' () 4 Petersburg State University : 5 -18.
Ermolenko, E.I., Donets, V.N., Dmitrieva, Y.V., Ilyasov, Y.Y., Suvorova, M.A. and Gromova, L.V., 2009. Influence of probiotic enterococci on functional characteristics of rat bowel under dysbiosis induced by antibiotics. Bulletin of St. Petersburg State University 1: 157-167.
'Influence of probiotic enterococci on functional characteristics of rat bowel under dysbiosis induced by antibiotics ' () 1 Petersburg State University : 157 -167.
European Commission (EC, 1986). Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal of the European Union L 358: 1-28.
Fedorova, I.A. and Danilenko, V.N., 2014. Immunogenic properties of a probiotic component of the human gastroenteric tract microbiota. Uspekhisovremennoybiologii. Biology Bulletin Reviews 134: 99-100.
'Immunogenic properties of a probiotic component of the human gastroenteric tract microbiota ' () 358 Biology Bulletin Reviews : 1 -28.
Galdeano, C.M., De Moreno de Blance, A., Vinderola, G., Bonet, M.E. and Perdigon, G., 2007. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clinical and Vaccine Immunology 14: 484-492.
'Proposed model: mechanisms of immunomodulation induced by probiotic bacteria ' () 14 Clinical and Vaccine Immunology : 484 -492.
Gómez-Hurtado, I., Santacruz, A., Peiró, G., Zapater, P., Gutiérrez, A., Pérez-Mateo, M., Sanz, Y. and Francés, R., 2011. Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis. PLoS ONE 6: e23037.
'Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis ' () 6 PLoS ONE : e23037.
Gupta, M. and Bajaj, B.K., 2016. Selection criteria for probiotics and potential of cereal based food products as novel probiotic-carriers. Current Nutrition & Food Science 12: 157-174.
'Selection criteria for probiotics and potential of cereal based food products as novel probiotic-carriers ' () 12 Current Nutrition & Food Science : 157 -174.
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11: 506-514.
'Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic ' () 11 Nature Reviews Gastroenterology & Hepatology : 506 -514.
Hooper, L.V., Littman, D.R. and Macpherson, A.J., 2012. Interactions between the microbiota and the immune system. Science 336: 1268-1273.
'Interactions between the microbiota and the immune system ' () 336 Science : 1268 -1273.
Karaseva, A., Tsapieva, A., Pachebat, J. and Suvorov, A., 2016. Draft genome sequence of probiotic Enterococcus faecium strain L-3. Genome Announcements 4: e01622-15.
'Draft genome sequence of probiotic Enterococcus faecium strain L-3 ' () 4 Genome Announcements : e01622 -15.
Ki Cha, B., Mun Jung, S., Hwan Choi, C., Song, I.D., Woong Lee, H., Joon Kim, H., Hyuk, J., Kyung Chang, S., Kim, K., Chung, W.S. and Seo, J.G., 2012. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Gastroenterology 46: 220-227.
'The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial ' () 46 Journal of Clinical Gastroenterology : 220 -227.
Lan, J.G., Cruicshank, S.M., Singh, J.C., Farrar, M., Lodge, J.P., Felsburg, P.J. and Carding, S.R., 2005. Different cytokine response of primary colonic epithelial cells to commensal bacteria. World Journal of Gastroenterology 11: 3375-3384.
'Different cytokine response of primary colonic epithelial cells to commensal bacteria ' () 11 World Journal of Gastroenterology : 3375 -3384.
Lebeer, S., Vanderleyden, J. and De Keersmaecker, S.C., 2010. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nature Reviews Microbiology 8: 171-184.
'Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens ' () 8 Nature Reviews Microbiology : 171 -184.
Lewis, K., Lutgendorff, F., Phan, V., Söderholm, J.D., Sherman, P.M. and McKay, D.M., 2010. Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflammatory Bowel Diseases 16: 1138-1148.
'Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate ' () 16 Inflammatory Bowel Diseases : 1138 -1148.
Lin, L. and Zhang, J., 2017. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunology 18: 2.
'Role of intestinal microbiota and metabolites on gut homeostasis and human diseases ' () 18 BMC Immunology : 2.
Louis, P. and Flint, H.J., 2009. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiology Letters 294: 1-8.
'Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine ' () 294 FEMS Microbiology Letters : 1 -8.
Markov, A.G., Falchuk, E.L., Kruglova, N.M., Rybalchenko, O.V., Fromm, M. and Amasheh, S., 2014. Comparative analysis of theophylline and cholera toxin in rat colon reveals an induction of sealing tight junction proteins. Pflügers Archiv-European Journal of Physiology 466: 2059-2065.
'Comparative analysis of theophylline and cholera toxin in rat colon reveals an induction of sealing tight junction proteins ' () 466 Pflügers Archiv-European Journal of Physiology : 2059 -2065.
McFarland, L.V., 1998. Epidemiology, risk factors and treatments for antibiotic associated diarrhea. Digestive Diseases 16: 292-307.
'Epidemiology, risk factors and treatments for antibiotic associated diarrhea ' () 16 Digestive Diseases : 292 -307.
McFarland, L.V., 2014. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open 4: e005047.
'Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review ' () 4 BMJ Open : e005047.
Mileti, E., Matteoli, G., Iliev, I.D. and Rescigno, M., 2009. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS ONE 4: e7056.
'Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy ' () 4 PLoS ONE : e7056.
Miquel, S., Martín, R., Rossi, O., Bermúdez-Humarán, L., Chatel, J., Sokol, H., Thomas, M., Wells, J. and Langella, P., 2013. Faecalibacterium prausnitzii and human intestinal health. Current Opinion in Microbiology 16: 255-261.
'Faecalibacterium prausnitzii and human intestinal health ' () 16 Current Opinion in Microbiology : 255 -261.
Mu, C., Yang, Y. and Zhu, W., 2015. Crosstalk between the immune receptors and gut microbiota. Current Protein and Peptide Science 16: 622-631.
'Crosstalk between the immune receptors and gut microbiota ' () 16 Current Protein and Peptide Science : 622 -631.
Omenetti, S. and Pizarro, T.T., 2017. The Treg/Th17 axis: a dynamic balance regulated by the gut microbiome. Frontiers in Immunology 6: 639.
'The Treg/Th17 axis: a dynamic balance regulated by the gut microbiome ' () 6 Frontiers in Immunology : 639.
Patel, R. and DuPont, H.L., 2015. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clinical Infectious Diseases 60: 108-121.
'New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics ' () 60 Clinical Infectious Diseases : 108 -121.
Qiu, X., Zhang, M., Yang, X., Hong, N. and Yu, C., 2013. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. Journal of Crohn’s and Colitis 7: 558-568.
'Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis ' () 7 Journal of Crohn’s and Colitis : 558 -568.
Rajput, I.R., Li, L.Y., Xin, X., Wu, B.B., Juan, Z.L., Cui, Z.W., Yu, D.Y. and Li, W.F., 2013. Effect of Saccharomyces boulardii and Bacillus subtilis B10 on intestinal ultrastructure modulation and mucosal immunity development mechanism in broiler chickens. Poultry Science 92: 956-965.
'Effect of Saccharomyces boulardii and Bacillus subtilis B10 on intestinal ultrastructure modulation and mucosal immunity development mechanism in broiler chickens ' () 92 Poultry Science : 956 -965.
Rieger, J., Janczyk, P., Hünigen, H., Neumann, K. and Plendl, J., 2015. Intraepithelial lymphocyte numbers and histomorphological parameters in the porcine gut after Enterococcus faecium NCIMB 10415 feeding in a Salmonella Typhimurium challenge. Veterinary Immunology and Immunopathology 164: 40-50.
'Intraepithelial lymphocyte numbers and histomorphological parameters in the porcine gut after Enterococcus faecium NCIMB 10415 feeding in a Salmonella Typhimurium challenge ' () 164 Veterinary Immunology and Immunopathology : 40 -50.
Sekirov, I., Tam, N., Jogova, M., Robertson, M., Li, Y., Lupp, C. and Finlay, B., 2008. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infection and Immunity 76: 4726-4736.
'Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection ' () 76 Infection and Immunity : 4726 -4736.
Sheil, B., Shanahan, F. and O’Mahony, L., 2007. Probiotic effects on inflammatory bowel disease. Journal of Nutrition 137: 819-824.
'Probiotic effects on inflammatory bowel disease ' () 137 Journal of Nutrition : 819 -824.
Shifrin, D.A., McConnell, R.E., Nambiar, R., Higginbotham, J.N., Coffey, R.J. and Tyska, M.J., 2012. Enterocyte microvillus-derived vesicles detoxify bacterial products and regulate epithelial-microbial interactions. Current Biology 22: 627-631.
'Enterocyte microvillus-derived vesicles detoxify bacterial products and regulate epithelial-microbial interactions ' () 22 Current Biology : 627 -631.
Suvorov, A.N., 2013. Gut microbiota, probiotics, and human health. Bioscience of Microbiota, Food and Health 32: 81-91.
'Gut microbiota, probiotics, and human health ' () 32 Bioscience of Microbiota, Food and Health : 81 -91.
Swidinski, V., Loening-Baucke, V. and Herber, A., 2009. Mucosal flora in Crohn’s disease and ulcerative colitis – an overview. Journal of Physiology and Pharmacology 60: 61-71.
'Mucosal flora in Crohn’s disease and ulcerative colitis – an overview ' () 60 Journal of Physiology and Pharmacology : 61 -71.
Tarasova, E., Yermolenko, E., Donets, V., Sundukova, Z., Bochkareva, A., Borschev, I., Suvorova, M., Ilyasov, I., Simanenkov, V. and Suvorov, A., 2010. The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics. Beneficial Microbes 1: 265-270.
'The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics ' () 1 Beneficial Microbes : 265 -270.
Thomas, C.M. and Versalovic, J., 2010. Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes 1: 148-163.
'Probiotics-host communication: modulation of signaling pathways in the intestine ' () 1 Gut Microbes : 148 -163.
Timmerman, H.M., Koning, C.J.M., Mulder, L., Rombouts, F.M. and Beynen, A.C., 2004. Monostrain, multistrain and multispecies probiotics a comparison of functionality and efficacy. International Journal of Food Microbiology 96: 219-233.
'Monostrain, multistrain and multispecies probiotics a comparison of functionality and efficacy ' () 96 International Journal of Food Microbiology : 219 -233.
Ubeda, C., Taur, Y., Jenq, R.R., Equinda, M.J., Son, T., Samstein, M., Viale, A., Socci, N.D., Van den Brink, M.R., Kamboj, M. and Pamer, E.G. 2010. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. Journal of Clinical Investigation 120: 4332-4341.
'Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans ' () 120 Journal of Clinical Investigation : 4332 -4341.
Wall, R., Marques, T.M., O’Sullivan, O., Ross, R.P., Shanahan, F., Quigley, E.M., Dinan, T.G., Kiely, B., Fitzgerald, G.F., Cotter, P.D., Fouhy, F. and Stanton, C., 2012. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. American Journal of Clinical Nutrition 95: 1278-1287.
'Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota ' () 95 American Journal of Clinical Nutrition : 1278 -1287.
All Time | Past 365 days | Past 30 Days | |
---|---|---|---|
Abstract Views | 231 | 117 | 23 |
Full Text Views | 16 | 5 | 0 |
PDF Views & Downloads | 25 | 11 | 0 |
The biological effects of three probiotic strains Lactobacillus rhamnosus K32, Bifidobacterium longum GT15, Enterococcus faecium L3 and their mixture were studied using a model of dysbiosis induced in rats by antibiotics. It was found that after taking different probiotics intestinal microbiota changed in a strain-specific manner. The maximal activity against pathogens was revealed after the administration of a mixture of bacterial strains under study or a single strain of enterococci. The strain E. faecium L3 showed the most activity against both Klebsiella spp. and Bacteroides fragilis. It helped to restore the original content of Faecalibacterium prausnitzii. The number of Klebsiella spp. was the same in the group receiving L. rhamnosus K32 and the group of animals, which was not consuming probiotics. Different probiotic strains included in the composition had various immunological effects. Probiotic bifidobacteria, enterococci and the mixture of three probiotics stimulated of mRNA expression of interleukin (IL)-10 in mesenteric lymph nodes. The changes in microbiota after consuming an enterococcal probiotic correlated with an increase in transforming growth factor (TGF)-β and IL-10 content in blood serum and an increase of the intestinal mucus layer. Consumption of L. rhamnosus K32 led to the stimulation of IL-8 expression in mesenteric lymph nodes. Control group not receiving probiotics was characterised by expression of pro-inflammatory cytokines, damage of epithelial cells and the destruction of their tight junctions. The damage to the ultrastructure of the mucosa was prevented in all the groups taking probiotics.
All Time | Past 365 days | Past 30 Days | |
---|---|---|---|
Abstract Views | 231 | 117 | 23 |
Full Text Views | 16 | 5 | 0 |
PDF Views & Downloads | 25 | 11 | 0 |